Rejuvenate Bio

Reversing age-related decline — proven in animals, advancing to humans

  • Raising on Wefunder
  • Healthcare · United States

The raise in figures

Raised

US$3,897,781

Investors
1,491
Time left
31 days

Last updated

↳ Wefunder · checked 2 min ago

About this raise

Rejuvenate Bio has an open equity crowdfunding raise on Wefunder. Based in the United States, Rejuvenate Bio sits in Wefunder’s Healthcare category. The round is made under Regulation Crowdfunding (Reg CF).

So far it has raised $3.89M from 1,491 investors.

It runs from to , a run of 221 days.

For comparison, the 16 other raises in Wefunder’s Healthcare category over the past 12 months drew a median of 69 investors. Its 1,491 investors so far put it above the median investor count.

Under Reg CF, a US company can raise from anyone, not just accredited investors, as long as the offering runs through an SEC-registered intermediary. The figures here come from Wefunder, as of Raise Sonar’s last check on .

Live

Closes in 31 days

Day 191/221

Close date moved from Sat 1 May to Sat 5 Dec.

Launched Tue 28 Apr28 Apr Day 191 of 221 Closes Sat 5 Dec5 Dec

  • Next alerts: 7 days (Sat 28 Nov), 72 hours (Wed 2 Dec) and 24 hours (Fri 4 Dec) before close

Funding history

554 readings

Rejuvenate Bio: amount raised over time The amount raised rose from US$3,142,271 on 11 October 2026 to US$3,897,781 on 4 November 2026, over 554 readings.
Rejuvenate Bio: amount raised per day, last 14 days 21 Oct US$75,913; 22 Oct US$123,760; 23 Oct US$32,183; 24 Oct US$13,927; 25 Oct US$6,008; 26 Oct US$29,282; 27 Oct US$169,041; 28 Oct US$15,491; 29 Oct US$177,056; 30 Oct -US$82,788; 31 Oct US$3,562; 1 Nov US$17,150; 2 Nov US$3,815; Last 24 hours US$5,769. Usual pace US$17,150 a day, the median of the previous 7 days. 21 Oct: US$75,91322 Oct: US$123,76023 Oct: US$32,18324 Oct: US$13,92725 Oct: US$6,00826 Oct: US$29,28227 Oct: US$169,04128 Oct: US$15,49129 Oct: US$177,05630 Oct: -US$82,78831 Oct: US$3,5621 Nov: US$17,1502 Nov: US$3,815Last 24 hours: US$5,769
Raised US$5,769 in the last 24 hours, 0.3× its usual daily pace (median of the previous 7 days).

About Rejuvenate Bio

Summarised by Raise Sonar from Rejuvenate Bio’s Wefunder pitch

Rejuvenate Bio develops one-shot gene therapies intended to target the root causes of aging and chronic disease. Its lead therapy uses an AAV8 vector to deliver the FGF21 gene to the liver. The company earns partner payments from animal health collaborations, including milestone payments and projected royalties. It is based in San Diego, CA. This raise is described as moving the company toward cash flow positivity and advancing its animal and human clinical trials.

Read the full pitch on Wefunder (opens in a new tab)

More like this

Questions about Rejuvenate Bio’s raise

When does Rejuvenate Bio’s crowdfunding raise close?

Rejuvenate Bio’s raise on Wefunder closes on Saturday 5 December 2026 at 04:59 GMT. Its close date was moved earlier, from 1 May 2027.

What regulation is Rejuvenate Bio’s raise under?

Rejuvenate Bio’s raise is under Regulation Crowdfunding (Reg CF). Reg CF is the SEC’s exemption that lets a US company raise from the general public, not only accredited investors, through an SEC-registered funding portal or broker-dealer.

How much has Rejuvenate Bio raised so far?

As of 4 November 2026, Rejuvenate Bio has raised $3.89M from 1,491 investors on Wefunder.

More raises on Wefunder

All Wefunder raises

Live now

Opening soon

About Raise Sonar

Every live equity crowdfunding raise, in one place

We track raises across Crowdcube, Republic, Wefunder, StartEngine and more, and tell you when they open and before they close.

  • Launch alerts

    An email when a raise matching your filters opens.

  • Close reminders

    Follow a raise and hear from us 72 and 24 hours before it closes.

  • One search, every platform

    Filter live raises by sector, country, minimum and platform.

  • The weekly newsletter

    New raises and raises closing soon, every Monday.